PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's financial stability and solvency. Value investors pay close attention to leverage and liquidity risk, ensuring the company has enough cushion to withstand downturns without impairing shareholder value.
-0.71
Negative D/E (negative equity) is a classic Benjamin Graham red flag. While possibly indicating distressed value, check for hidden liabilities and verify asset quality. Consider examining Current Ratio for immediate solvency.
-8.61
Net cash position is a classic Benjamin Graham green flag, but check if working capital management is too conservative. Consider examining Return on Capital to ensure efficiency.
-4.36
Negative coverage (negative EBIT) is a classic Benjamin Graham red flag. While possibly indicating turnaround potential, verify Current Ratio and Net Debt to EBITDA for overall financial health.
0.07
Current ratio below 0.8 - Danger zone. Walter Schloss would avoid unless clear refinancing path exists. Examine all debt metrics urgently.
No Data
No Data available this quarter, please select a different quarter.
